UCL IBIL Event: Boris v Corbyn v Trump - putting a price on patents, medicine and innovation By Annsley Merelle Ward on Friday, November 22, 2019 #IPKat AmeriKat compulsory licensing crown use ibil IP and pharma mr justice birss NHS Novartis open access open innovation Teva trade agreement ucl UK politics +
Beyond exclusion of pharmaceutical products from patentable subject matter as a solution to limited access to medicines in Africa By Chijioke Okorie on Wednesday, July 31, 2019 access to medicine Africa IP and pharma OAPI patents pharmaceutical industry TRIPS Agreement +
IP Pharma Challenges ... in Stockholm By Eleonora Rosati on Thursday, May 30, 2019 #IPKat Eleonora Rosati events IP and pharma pharma Silvia A. Carretta SIPLR Stockholm +